Baxter to Present at the 30th Annual J.P. Morgan Health Care Conference

Show Health and Fitness Publications

Thu, December 22, 2011

[ Thu, Dec 22nd 2011 ]: Market Wire

Heska to Present at the Sidoti & Company, LLC Semi-Annual New York Micro-Cap Conference

[ Thu, Dec 22nd 2011 ]: Market Wire

Abbott Initiates Clinical Trial to Study Drug Elu .. herapy for Treatment of Peripheral Artery Disease

[ Thu, Dec 22nd 2011 ]: Market Wire

Patent Issued for Treatment of Diabetes

[ Thu, Dec 22nd 2011 ]: Market Wire

CytRx Initiates International Phase 2b Clinical T .. ial with INNO-206 in Advanced Soft Tissue Sarcoma

[ Thu, Dec 22nd 2011 ]: Market Wire

Poniard Pharmaceuticals and Allozyne Terminate Planned Merger

[ Thu, Dec 22nd 2011 ]: Market Wire

Pfizer Reports Results From Three Phase 4 Studies .. ne sulfate and naltrexone hydrochloride) Extended

[ Thu, Dec 22nd 2011 ]: Market Wire

Synageva BioPharma Completes Enrollment in Phase .. 2 for Late Onset LAL Deficiency and Announces Oth

[ Thu, Dec 22nd 2011 ]: Market Wire

ARCA biopharma Announces Private Placement of $1.75 Million with Institutional Investors

[ Thu, Dec 22nd 2011 ]: Market Wire

SecureAlert Inc. Announces Contract to Monitor Juvenile Offenders in Clark County, Nevada

[ Thu, Dec 22nd 2011 ]: Market Wire

Valeant Pharmaceuticals to Hold Conference Call to Announce 2012 Financial Guidance

[ Thu, Dec 22nd 2011 ]: Market Wire

CareFusion Provides Update on Previously Announced Ventilator Recall

[ Thu, Dec 22nd 2011 ]: Market Wire

Valeant Pharmaceuticals Completes Acquisition of iNova

[ Thu, Dec 22nd 2011 ]: Market Wire

Sucampo Reports Conclusion of Arbitration Hearing

[ Thu, Dec 22nd 2011 ]: Market Wire

Dr. Rob Koremans to succeed Dr. Gerard van Odijk as President and CEO of Teva Europe

[ Thu, Dec 22nd 2011 ]: Market Wire

Curis Announces Collaborator Rocheas Submission o .. lication for Vismodegib in Advanced Basal Cell Ca

[ Thu, Dec 22nd 2011 ]: Market Wire

AVEO Announces Patient Enrollment in Phase 2 Clin .. mbination with mFOLFOX6 in Patients with Advanced

Wed, December 21, 2011

[ Wed, Dec 21st 2011 ]: Market Wire

Crystal Research Associates, LLC Issues Executive .. rview (EIO) on InVivo Therapeutics Holdings Corp.

[ Wed, Dec 21st 2011 ]: Market Wire

OPKO Health To Acquire FineTech Pharmaceutical Ltd.

[ Wed, Dec 21st 2011 ]: Market Wire

Celldex Completes Accrual of CDX-011 Phase 2b aEMERGEa Study in Advanced Breast Cancer

[ Wed, Dec 21st 2011 ]: Market Wire

Ligand Enters into Platform Captisol License and Supply Agreements with Lilly

[ Wed, Dec 21st 2011 ]: Market Wire

PharmaGap Completes In Vivo Study Protocol in Ovarian Cancer

[ Wed, Dec 21st 2011 ]: Market Wire

IBEX Reports First Quarter Fiscal 2012 Results

[ Wed, Dec 21st 2011 ]: Market Wire

Repligen Announces Submission of New Drug Applica .. ved Pancreatic Imaging In Patients with Pancreati

[ Wed, Dec 21st 2011 ]: Market Wire

Titan Pharmaceuticals Adopts Stockholder Rights P .. iles Shelf Registration of Securities on Form S-3

[ Wed, Dec 21st 2011 ]: Market Wire

Implant Sciences' Quantum Sniffer QS-B220 Achieves CE Certification

[ Wed, Dec 21st 2011 ]: Market Wire

Adeona Announces Proposed Name Change to Syntheti .. tment of John Monahan, Ph.D., as Senior Vice Pres

[ Wed, Dec 21st 2011 ]: Market Wire

Strategic Global Investments, Inc. Announces Alli .. ce Support, Corp., Preferred Provider of Anheuser

[ Wed, Dec 21st 2011 ]: Market Wire

Exelixis Licenses PI3K-Delta Program to Merck

[ Wed, Dec 21st 2011 ]: Market Wire

Capital Senior Living Corporation to Present at S .. l Micro-Cap Conference on Monday, January 9, 2012

[ Wed, Dec 21st 2011 ]: Market Wire

PAREXEL Introduces Executive Briefing Series on P .. erging and Mid-size Biopharma in Achieving Better

[ Wed, Dec 21st 2011 ]: Market Wire

Denali Concrete Management Inc. Announces the Com .. Enrollment for the Phase 3 Dry Eye Syndrome Study

[ Wed, Dec 21st 2011 ]: Market Wire

Matthew Hunt Appointed Managing Director, Health Services, Aetna International

Tue, December 20, 2011

[ Tue, Dec 20th 2011 ]: Market Wire

Savient Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference

[ Tue, Dec 20th 2011 ]: Market Wire

Amerigroup Foundation Presents Grant to Empty Stocking Fund

[ Tue, Dec 20th 2011 ]: Market Wire

Arrowhead Reports Fiscal 2011 Fourth Quarter and Year-End Financial Results

[ Tue, Dec 20th 2011 ]: Market Wire

Healthways Revises Financial Guidance for 2011

[ Tue, Dec 20th 2011 ]: Market Wire

Masimo to Present at 30th Annual J.P. Morgan Healthcare Conference

[ Tue, Dec 20th 2011 ]: Market Wire

Salix Pharmaceuticals Completes Acquisition of Oceana Therapeutics

[ Tue, Dec 20th 2011 ]: Market Wire

OPKO Health Announces Commencement of U.S. Clinic .. for Point-of-Care Prostate Specific Antigen Test

[ Tue, Dec 20th 2011 ]: Market Wire

Ergoresearch LTD Annonces its Best First Quarter Ever

[ Tue, Dec 20th 2011 ]: Market Wire

Isis Pharmaceuticals Announces Its R&D Webcast Presentation

[ Tue, Dec 20th 2011 ]: Market Wire

Compugen to Broaden and Accelerate Monoclonal Antibody Program for Oncology and Immunology

[ Tue, Dec 20th 2011 ]: Market Wire

Imaging Diagnostic Sells Its CTLM System to China

[ Tue, Dec 20th 2011 ]: Market Wire

Covidien kondigt CE-markering aan voor Nellcora" Respiration Rate Software

[ Tue, Dec 20th 2011 ]: Market Wire

Allezoe Medical Holdings (ALZM) Completes Exclusive Licensing Deal for HPV Diagnostic Technology

[ Tue, Dec 20th 2011 ]: Market Wire

Dynavax Initiates Proof of Mechanism Trial in Lupus Patients

[ Tue, Dec 20th 2011 ]: Market Wire

Improved Treatments for Brain Cancers Highlighted .. at Annual Society of Neuro-Oncology (SNO) Meeting

[ Tue, Dec 20th 2011 ]: Market Wire

Repligen Completes Acquisition of Novozymes Biopharma Sweden AB

Baxter to Present at the 30th Annual J.P. Morgan Health Care Conference

//health-fitness.news-articles.net/content/2011/ .. th-annual-j-p-morgan-health-care-conference.html

Published in Health and Fitness on Wednesday, December 21st 2011 at 6:25 GMT by Market Wire
^{🞛 This publication is a summary or evaluation of another publication}

DEERFIELD, Ill.--([ BUSINESS WIRE ])--Baxter International Inc. (NYSE: BAX) announced today that it will present at the 30^th Annual J.P. Morgan Health Care Conference on Tuesday, January 10, 2012, at 2:30 p.m. (PT) or 5:30 p.m. (ET).

The live webcast of Baxteras presentation can be accessed from the Baxter corporate website at [ www.baxter.com ] and will be available for replay through February 9, 2012.

Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.